Skip to content

Combination of Targeted temperature management and Thrombectomy after acute Ischemic Stroke (COTTIS-2) – a randomised controlled study

Combination of Targeted temperature management and Thrombectomy after acute Ischemic Stroke (COTTIS-2) – a randomised controlled study - COTTIS-2

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
DRKS
Registry ID
DRKS00031086
Enrollment
400
Registered
2024-02-19
Start date
2024-07-01
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I63

Interventions

Group 1: Intervention: Immediately induced hypothermia to 35°C (measured esophagially) by transnasal colling with RhinoChill prior to thrombectomy followed by surface cooling for 6 hours after recanal

Sponsors

Universitätsklinikum Freiburg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: o Pre-stroke modified Rankin Scale (mRS) 0-2 o Acute ischemic stroke with NIHSS >5 o Indication for endovascular treatment (thrombectomy) o Intracranial occlusion of the M1 or M2 segment of the middle cerebral artery (MCA) or internal carotid artery (ICA) or tandem occlusion on CT-angiography or MR-angiography o Time window: -Last seen normal to groin puncture 5 -Last seen normal to groin puncture 6-24h or unknown time window: significant mismatch imaging according to the eligibility criteria of the DEFUSE-3 trial: - Infarct core 15ml (Tmax >6sec) - Ratio penumbra/core >1.8 o with or without iv thrombolysis with rtPA

Exclusion criteria

Exclusion criteria: o Patients with an intranasal obstruction that prevents complete insertion of the nasal cannula should not be treated with the RhinoChill system. o Known severe hemorrhagic diathesis (International Normalized Ratio (INR) >3.0, partial thromboplastin time (PTT) > 70s, platelet count < 50.000/µl) o Brain trauma or neurovascular surgery/intervention <3 months o Severe infection o Pregnant women or women of childbearing potential (women of childbearing potential with negative pregnancy test may be included) o Known cerebral vasculitis o Proof of bleeding in cerebral CT or MRI (cerebral microbleeds in MRI [hypertensive or in the context of cerebral amyloid angiopathy] is permitted). o Life expectancy < 6 months

Design outcomes

Primary

MeasureTime frame
The proportion of patients with good neurological outcome after 3 months as defined by modified Rankin Scale (mRS) of 0-2 or back to baseline before stroke.

Secondary

MeasureTime frame
1) Infarction volume assessed in the standard CT 24 hours after thrombectomy 2) Increase of the infarct core based on imaging at the time of admission (DWI-MRI or CBF30% of initial infarction volume associated with a clinical deterioration in NIHSS score of at least 4 points within 24 hours after thrombectomy 2. Complications associated with additional hypothermia treatment : [Time span: from start of hypothermia to 24 hours after induction of cooling] - Nosebleed and pailing of the nose - Periorbital emphysema - Pneumocephalus (in 24-hour control CT) - Blood pressure, heart rate, oxygen saturation SO2 - Episodes with severe hypotension with systolic blood pressure 38°C, leukopenia/leucocytosis, purulent secretions with positive cultures) - Disturbances in electrolytes, renal function, coagulation (potassium, sodium, chloride, creatinine, INR, pTT, thrombocytes measured on admission before hypothermia and at 24 hours)

Countries

Germany

Contacts

Public ContactJürgen Bardutzky

Neurologie, Universität Freiburg

juergen.bardutzky@uniklinik-freiburg.de+49 761-270-53090

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026